Alnylam Pharmaceuticals, Inc. Equity-NMS: ALNY

Healthcare

Biotechnology

Buy/Sell an entire stock
or a fraction.
Powered by Vested Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly
Loading, Please wait...
Error in Fetching Data, Please retry later.
No data available.
Previous close :$154.39
Open :$154.48
Today's high :$154.5
Today's low :$149.32
52W low :$143.52
52W high :$218.88
1Y :-21.27%
5Y :64.45%
EPS(TTM): :-3.52
Shares O/S :125.95 M
Market cap :18.82 B

Compare with Other Stocks

Frequently Asked Questions

What is the share price of Alnylam Pharmaceuticals, Inc. today?

Alnylam Pharmaceuticals, Inc. (ALNY) share price as of March 29, 2024, is $149.45. If you are investing from India, you can always check the valuation in the INR before investing.

Can Indian Investors purchase shares of Alnylam Pharmaceuticals, Inc.?

Yes, Indian Investors can invest in the Alnylam Pharmaceuticals, Inc. (ALNY) Share by opening an international trading account with Angel One.

How can I purchase Alnylam Pharmaceuticals, Inc. shares in India?

Purchasing Alnylam Pharmaceuticals, Inc. (ALNY) share from India can be done by:
  1. Directly: By opening an international trading account with Angel One. The process would include KYC verification.
    The account activation takes a few minutes to a few hours, after which you can start buying Alnylam Pharmaceuticals, Inc. (ALNY) by making deposits in US dollars.
  2. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.

Can I buy Fractional shares of Alnylam Pharmaceuticals, Inc.?

Yes, you can purchase fractional shares of Alnylam Pharmaceuticals, Inc. (ALNY) or any other US company shares in Angel One for any dollar amount.

What is the market capitalization value of Alnylam Pharmaceuticals, Inc.?

The market capitalization of Alnylam Pharmaceuticals, Inc. on March 29, 2024, is $18.82 B.

In which sector Alnylam Pharmaceuticals, Inc. belongs?

Alnylam Pharmaceuticals, Inc. operates in the Healthcare sector, specifically in the Biotechnology industry.

What documents are required to invest in Alnylam Pharmaceuticals, Inc. stocks?

In order to invest in Alnylam Pharmaceuticals, Inc. (ALNY) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.)

From start to end, the process is digital and can be seamless.

About Alnylam Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc. is a clinical-stage company. The Company is engaged in developing mRNA cell therapies for the treatment of autoimmune diseases. The Company’s lead product candidate, Descartes-08, is an autologous mRNA CAR-T directed against the B cell maturation antigen (BCMA). Descartes-08 targets BCMA, which exists on the surface of long-lived plasma cells and plasmacytoid dendritic cells. Descartes-08 is in Phase IIb clinical development for patients with generalized myasthenia gravis (MG). Its other product candidate includes Descartes-15 and Descartes-33. Descartes-15 is a next-generation, autologous anti-BCMA mRNA CAR-T. Using its proprietary technology and manufacturing platform, it designed Descartes-15 to be more resistant than Descartes-08 to recycling of the CAR upon multiple antigen exposures. It is developing Descartes-33 to deliver a combination of therapeutic proteins that target key drivers in the pathogenesis of autoimmunity.